Ranok Therapeutics
PrivateLast Round
Series B
Aug 18, 2021
Total Funding Raised
$40M
Company Overview
Ranok Therapeutics is a drug discovery company that develops an innovative targeted protein degradation technology for the discovery and development of novel therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ranok Therapeutics Comparables
Compare Ranok Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealZen Therapeutics Co., Ltd. | 87% | |
| Plexium | 84% | |
| Cullgen | 84% | |
Ranok Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 18, 2021 | ||||
| Seed | Mar 27, 2020 |
Key People
Founding team and executive leadership
Ranok Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series B |
| Wu Capital | Series B |
| Lapam Capital | Series B |
Ranok Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ranok Therapeutics's valuation, stock price, and market status.